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Abstract
Background: More than 94 serotypes of Streptococcus pneumoniae have been described to date, however the
majority of disease is caused by approximately 20 serotypes. Some pneumococci do not react with commercially
available antisera used for serotyping and are thus regarded as non-serotypeable (NT). These pneumococci are
commonly isolated during carriage studies and very rarely cause invasive disease. Colonization may occur with
more than one serotype however disease with more than one serotype is rarely detected. Thus there are limited
data describing cases of pneumococcal disease caused by more than one isolate.
Results: In two cases of invasive pneumococcal disease in South Africa, a non-serotypeable and a serotypeable
isolate were co-detected during routine serotyping. A serotype 1 and 18C isolate were each co-detected with a
non-serotypeable isolate in 2009 (case A) and 2010 (case B), from cerebrospinal fluid and blood, respectively. Both
patients were 10–14 years old. For case A, the serotypeable isolate could not be obtained due to low representation
in the mixed culture. Using electron microscopy we confirmed lack of capsule for the non-serotypeable isolates.
Comparison of the case A non-serotypeable isolate with a serotype 1 genome revealed only the presence of the
rhamnose biosynthesis genes (rmlA, B, C and D) in the capsular locus, all other capsular genes were absent.
Nonetheless it had a multilocus sequence type (ST) associated with serotype 1 (ST217 and ribosomal ST3462) and its
core genome clustered with other ST217 isolates. The case B non-serotypeable isolate had all serotype 18C capsular
genes except for variation in the wchA and wze genes, compared to the 18C isolate. Both case B isolates were ST9817
and their core genomes were identical.
Conclusions: The ability of pneumococci to alter capsule production is a potential vaccine escape mechanism and
therefore non-serotypeable pneumococci should be monitored as such organisms may increase under vaccine
pressure.
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Background
Streptococcus pneumoniae (pneumococcus) is a com-
mensal of the human nasopharynx. However, occasion-
ally it evades the immune system and is an important
cause of invasive disease such as meningitis and bacter-
aemia, and non-invasive disease such as pneumonia and
acute otitis media. The polysaccharide capsule is known
to be a major virulence factor of the pneumococcus. It is
immunogenic and can be detected by specific antisera,
and hence forms the basis for serotyping and current
vaccines against pneumococcal disease. To date, more
than 94 serotypes have been described but the majority
of disease is caused by approximately 20 serotypes [1].
The most prevalent disease-causing serotypes have been
incorporated into currently used polysaccharide conju-
gate vaccines (PCV-7, -10 and -13). In South Africa,
PCV-7 was introduced into the Expanded Programme
for Immunisation in 2009 and replaced by PCV-13 in
2011 in a 2 + 1 schedule at 6, 14 and 40 weeks of age [2].
With the exception of serotypes 3 and 37, genes re-
sponsible for production of the polysaccharide capsule
are located in the capsular polysaccharide (cps) region in
a single locus flanked by the dexB and aliA genes [3].
The first four cps genes (cpsA, cpsB, cpsC and cpsD –
also known as wzg, wzh, wzd and wze, respectively) are
conserved among all serotypes and are involved in the
regulation and processing of the capsule [3]. Some
pneumococci do not react with commercially available
antisera used for serotyping and are thus regarded as
non-serotypeable (NT). These pneumococci are com-
monly isolated during carriage studies and very rarely
cause invasive disease [4]. Non-serotypability is due to
partial or complete loss of the cps gene cluster [5], re-
placement of cps genes with other genes [5–7], sequence
duplication [8] or single point mutations, commonly
within the wchA (also known as cpsE) gene [9, 10]. The
polysaccharide capsule plays an important role in the
pathogenesis of the pneumococcus as it provides
protection against complement-mediated phagocyt-
osis. Reduced levels of capsule expression are re-
quired for effective attachment to epithelial cells and
colonization [11].
While reviewing national surveillance data to identify
episodes of mixed invasive pneumococcal disease (IPD)
caused by two or more serotypes, we identified two cases
(subsequently referred to as case A and case B) whereby
one of the co-detected isolates was non-serotypeable
(NT). In each of the two cases, the serotypeable and the
NT variant was identified from a culture recovered from
the same specimen (cerebrospinal fluid for case A and
blood for case B). Given the rarity of NT isolates in
causing IPD we hypothesized that these NT isolates
were variants of their co-detected serotypeable isolates.
We therefore compared the genomes of these co-
detected NT and serotypeable isolates to determine their
relationships.
Results
Thirty-seven thousand eight hundred twenty-five cases
of IPD were reported from 2005 to 2013, of which 70 %
(26,475/37,825) had viable isolates. Serotype results were
available for nearly all cases with viable isolates (26,469/
26,475). A mixed culture with more than one serotype
detected (including non-serotypables) was identified for
41 (0.2 %) cases. In two cases, one of the co-detected
isolates was NT. These cases were reported in 2009
(case A) and 2010 (case B), respectively and the age
range for both was 10–14 year-old (Table 1). These two
mixed culture cases were identified during routine sero-
typing of cultures recovered from cerebrospinal fluid
(case A) and blood (case B). Case A was diagnosed with
meningitis and clinical information was not available for
case B to confirm diagnosis.
For case A, serotype 1 and NT S. pneumoniae were
identified from the same culture, with the NT isolate
representing approximately 98 % of the culture (using
the Quellung reaction). The case B isolates were identi-
fied as NT and 18C. In each of the two cases, the same
results were obtained by two different laboratory staff
performing the Quellung reaction on fresh overnight
cultures grown from the original transport medium.
After several attempts to separate the two variants, only
the NT isolate could be obtained for case A, however,
real-time PCR confirmed the presence of the serotype 1
wzy gene in the mixed culture. For case B, pure cultures
were obtained for both the 18C and the NT isolate. The
three isolates were susceptible to all tested antimicrobial
agents.
TEM confirmed the absence of capsular material
for the case A non-serotypeable isolate (Fig. 1). For
Table 1 Characteristics of two patients (case A and B) with
invasive Streptococcus pneumoniae serotypeable and non-
serotypeable co-disease, South Africa
Case A Case B
Age range in years 10–14 10–14
Gender male male
HIV status unkown unknown
Specimen cerebrospinal fluid blood






Isolated serotypes anon-serotypeable non-serotypeable
and 18C
aPure culture for serotype 1 could not be obtained due to its low
representation in the mixed culture (see Results for more information)
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case B, 50 to 120 nm thick capsular material was ob-
served around cells of the serotype 18C isolate, while
there was no capsular material identified for the NT
isolate (Fig. 1).
The genome coverage for the case A NT isolate was
320× and assemblies contained 33 contiguous sequences
with a total length of 2,023,465 bp. For the case B NT
isolate, the coverage was 355× and assemblies contained
91 contiguous sequences with a total length of
2,110,682 bp. The case B serotype 18C isolate genome
coverage was 310× and assemblies contained 78 contigu-
ous sequences with total a length of 2,115,055 bp.
Sequence analysis of the capsular locus of the case A
NT isolate revealed the absence of all but four capsular
genes [rhamnose biosynthesis genes (rmlA, B, C and D)]
(Fig. 2). The isolate was identified as ST217 and
rST3462. Because we did not obtain a pure culture for
the case A serotype 1 isolate, we compared the case A
NT genome sequence to genomes (n = 54) of ST217
serotype 1 isolates causing invasive disease in South
Africa available on S. pneumoniae PubMLST database
[12] to further confirm that this NT isolate was indeed a
serotype 1 variant. Except for the absence of genes in the
capsular region (Additional file 1: Figure S1); the NT core
genome was 100 % similar (in 100 % of the bootstrap
replications) to sequences of a serotype 1 isolate with
the same rMLST profile (rST3462) (Additional file 2:
Figure S2). It also clustered with ST217 clinical iso-
lates collected from 1989 to 2013.
For case B, the NT and 18C isolates shared the
same new ST (ST9817) and rMLST profile. The NT
isolate had all serotype 18C capsule-specific genes [3],
however variations were identified in the capsular
locus compared to the co-detected 18C isolate and
three other genotypically related invasive 18C isolates
from South Africa. A nucleotide insertion (472_473 insG)
that resulted in a translational frameshift, introducing a
stop codon in the wchA gene, was identified (Additional
file 3: Figure S3). A substitution (149C→A) in the wze
gene resulted in an amino acid change (T50K) (Additional
file 4: Figure S4). Genome sequence comparison of the
case B isolates revealed high similarity between the two
genomes (Additional file 5: Figure S5) with 100 %
identity between their core genomes (Additional file 6:
Figure S6).
Discussion
The polysaccharide capsule is an important com-
ponent of the pneumococcus that aids in evading the
immune system. Hence unencapsulated (non-serotypeable)
Fig. 1 Visualization of pneumococcal isolates using transmission electron microscopy (TEM). Capsular materials of non-serotypable pneumococcal
isolates causing mixed infections in two patients in South Africa were compared to capsular materials of serotypeable isolates. The two cases were
reported in 2009 (case A) and 2010 (case B). For case A non-serotypeable and a serotype 1 isolate were identified and for case B a non-serotypeable
and 18C isolates were identified. TEM of the case A non-serotypeable isolate is shown in a, TEM of serotype 1 clinical isolate used as a control in b,
TEMs of two non-serotypeable clinical isolates used as a controls in c and f, TEM of case B serotype 18C isolate in d, and case B non-serotypeable
isolate in e. Scale bar = 175 nm
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pneumococci rarely cause invasive disease. Nevertheless,
we describe two cases of invasive pneumococcal disease
caused simultaneously by what appears to be serotype-
able and non-serotypeable variants of the same strain.
Our hypothesis, that the NT isolates were variants of
their encapsulated counterparts that either lost their
capsules or had reduced levels of capsular expression
during the infection, is supported by the lack of capsule
for both NT isolates from the two cases. Both NT iso-
lates were sequence types of major clones circulating
among encapsulated isolates in South Africa [13]. One
NT isolate was ST217, the dominant serotype 1 clone
in South Africa [13]. The second isolate was a new
sequence type (ST9817) that belonged to the ST1016
clonal complex, a predominant clonal complex among
serotype 18C isolates in South Africa [13].
Since the NT isolates from both cases were sequence
types commonly associated with serotype 1 and 18C, we
aligned their cps sequences to that of serotype 1 and
18C, respectively. The non-serotypability of the ST217
isolate appears to be caused by the deletion of genes
within the cps region. This mechanism is common
among NT isolates with a serotype 1 genetic back-
ground. Scott et al. [14], analysed 28 NT isolates from
IPD patients and identified eight isolates with partial
deletion of the capsular locus. Four of the eight isolates
were a sequence type associated with serotype 1 (ST227)
and, similar to our ST217 isolate, only had the rhamnose
biosynthesis genes (rmlA, B, C and D) in their capsular
region. Similarly, four IPD NT isolates analysed by Salter
et al. [15] that were ST227 only had rmlA, B, C and D
present in their capsular locus. Five additional ST217
NT isolates that were identified among our collection of
IPD surveillance isolates and were analysed as part of
another study also had only the four rhamnose biosyn-
thesis genes present in the capsular locus (unpublished
data). The deletion of the cps genes in our ST217 non-
serotypeable isolate could be transposon mediated as the
deleted serotype 1 genes are flanked by transposase
genes (IS1167). We were unable to isolate the encapsu-
lated variant (serotype 1) from this case due to its low
representation (approximately 2 %) in the mixed culture.
Nevertheless, detection of the serotype 1 wzy gene
(absent in the genome sequence of the NT isolate) in
the mixed culture by real-time PCR supports the pres-
ence of serotype 1 in that culture. Our genotypic results
also confirm that the NT isolate is a serotype 1 variant
as both the sequence type and ribosomal MLST profile
are exclusively associated with serotype 1 (ST217 and
rST3462). In addition, phylogenetic analysis showed that
its core genome clustered with those of other invasive
ST217 serotype 1 isolates circulating in South Africa
during the same period.
In the second case, the NT isolate had an intact cps
locus with all serotype 18C capsular genes with the
exception of two capsular genes that were variable, com-
pared to the serotype 18C isolate from the same patient.
Variation in the wze gene resulted in an amino acid
change within the protein. Together with wzd, wze
encodes proteins responsible for the export of the ma-
ture polysaccharide to the cell surface [3]. The wze gene
encodes an auto-phosphorylating protein-tyrosine kinase
which is inhibited by aerobic microenvironments, and is
thought to be one of the factors causing decreased
capsular expression in host environments with higher
oxygen levels such as the nasopharynx [11, 16]. Previous
studies have demonstrated that mutations in the wze
gene can inhibit capsule production [11, 16, 17]. An
insertion that introduced a premature stop codon in the
wchA gene was identified in our NT isolate. We suspect
that this insertion may be responsible for the loss
of capsule expression in our isolate as wchA encodes
the initial transferase that catalyzes the transfer of
glucose-phosphate to the lipid carrier during capsular
polysaccharide biosynthesis [18]. Melchior et al. [19]
described two mutations in the wchA gene (a
a 
b 
Fig. 2 Schematic diagram representing capsular polysaccharide loci of a pneumococcal non-serotypeable and serotype 1 isolate. The schematic
diagram represents comparison between the capsular polysaccharide (cps) locus of a non-serotypeable isolate (b) co-detected with a serotype 1
isolate during an invasive disease episode in South Africa, 2009, and the cps locus of an invasive serotype 1 clinical isolate from South Africa (a).
Transposases are indicated by grey arrows and flanking repeated sequences by lines within the arrow delimitations
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nucleotide deletion at position 910 and a substitution
at position 1081) in two invasive non-serotypeable
isolates with serotype 7F capsular genes both of which
introduced premature stop codons in the wchA gene.
Although the positions of these mutations differed
from that of our isolate, both resulted in a premature
stop codon. In another study, Schaffner et al. [9] re-
covered a NT isolate, with serotype 18C capsular
locus, from the nasopharynx of a child with otitis
media. The variations identified in our NT isolate
with serotype 18C capsular genes differ from the
wchA single base substitution (C1135G) described in
the Schaffner study.
Repeated sub-culturing in the laboratory may lead to a
change in phenotype [20] or the cultures may have be-
come mixed as a result of laboratory error. It is unlikely
that this occurred in this instance given the rarity of
these cases in our laboratory and the correlating geno-
typic data between the case B variants. It is favourable
for the pneumococcus to have reduced levels of capsule
for effective attachment to epithelial cells in the naso-
pharynx however the capsule is required for survival of
the pneumococcus during invasive disease as it provides
protection against complement-mediated phagocytosis
[11]. We therefore suspect that both variants may have
been present in the nasopharynx and invaded simultan-
eously. Unfortunately we don’t have corresponding naso-
pharyngeal isolates from these patients to confirm this
hypothesis. Another possibility is that the serotypeable
variant could have invaded and mutated in the host to
lose the capsule. Survival of the NT isolates in the
blood and meninges without protection of the capsule
is highly irregular but may be related to host factors
such as suppressed immune status due to underlying
diseases such as HIV infection [21]. Unfortunately we
did not have all the relevant patient information to
assess if this was true.
Conclusions
We identified two different vaccine-serotype isolates that
appear to have lost their capsules during two separate
episodes of invasive disease. Non-serotypeable pneumo-
cocci are not targeted by current pneumococcal vaccines
and thus present a potential mechanism whereby the or-
ganism could escape vaccine pressure. In addition, unen-
capsulated isolates have higher recombination efficiency
than encapsulated pneumococci and therefore provide a
reservoir of antibiotic resistance genes for genetic ex-
change [22]. Antibiotics coupled with routine PCV use
may drive the selection of non-serotypeable invasive
variants and thus prevalence and genotypes of such
pneumococci should be monitored to identify capsular




Isolates were obtained through Group for Enteric, Respira-
tory and Meningeal Disease Surveillance (GERMS-SA), a
national, laboratory-based surveillance system for IPD
in South Africa [23]. Identification of S. pneumoniae
was based on standardized methodologies using opto-
chin as well as bile solubility on any optochin non-
susceptible strains [24]. Once identified, a sweep was
inoculated onto Dorset transport medium [Diagnostic
Media Products (DMP), Johannesburg, South Africa]
and sent to the NICD [25]. Isolates were sub-cultured
on arrival at our reference laboratory on 5 % horse
blood agar plates (DMP) in the presence of an optochin
disc (Mast Group Ltd., United Kingdom). Cultures were
stored in 10 % skim milk (DMP) at −70 °C.
Serotyping and antimicrobial susceptibility testing
Serotypes were determined by the Quellung method
using serotype-specific antisera (Statens Serum Insti-
tut, Copenhagen, Denmark) [26]. A sweep of culture
was initially serotyped and if a mixed culture was sus-
pected, serotyping was repeated on single colonies.
Antimicrobial susceptibility testing was performed
by the broth microdilution method using commer-
cially prepared Sensititre-SASP2 panels (Trek Diag-
nostics Inc., Cleveland, OH). Results were interpreted
according to Clinical and Laboratory Standards
Institute guidelines and breakpoints [27]. The follow-
ing antimicrobial agents were tested: penicillin G,
ceftriaxone, amoxicillin, erythromycin, clindamycin,
chloramphenicol, tetracycline, rifampicin, cotrimoxa-
zole, ofloxacin, linezolid and vancomycin. Isolates
were considered to be non-susceptible to penicillin at
minimum inhibitory concentrations (MICs) ≥0.12 mg/
L using the oral penicillin meningitis breakpoints. For
other antimicrobials, isolates were defined as non-
susceptible if they were intermediately or fully resist-
ant to the agent tested.
Identification of cases with mixed cultures of a
non-serotypeable and a serotypeable isolate
Cases reported for IPD surveillance from 2005 to 2013
were reviewed. A mixed culture was defined as the sim-
ultaneous identification of at least two serotypes (includ-
ing non-serotypeable isolates) either from the same
normally-sterile site specimen of an IPD patient or from
two or more normally-sterile site specimens obtained
from an IPD patient within 21 days of each other. In this
study, we characterized isolates from cases where at least
one of the co-identified isolates was non-serotypeable.
Such cases were detected during routine serotyping by
Quellung if an isolate reacted partially with a specific
antiserum pool. In such cases, the stored isolate and
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Dorset transport medium were sub-cultured for single
colonies on 5 % horse blood agar plates (DMP). Follow-
ing 24 h incubation at 37 °C in 5 % CO2, the plates were
examined for differences in colony morphology and the
Quellung reaction was repeated on different colony
types. The colonies were sub-cultured, re-identified and
serotyped to determine if they were true mixtures.
Real-time PCR, targeting the lytA gene, was used to
confirm non-serotypeable isolates as S. pneumoniae
[28]. Non-serotypeable isolates were defined as
pneumococcal isolates confirmed by lytA real-time
PCR and for which a serotype could not be assigned by
the Quellung method. For the serotypeable isolate and
mixed cultures where isolates of different serotypes
could not be separated, serotype was confirmed using
real-time PCR [29].
Transmission electron microscopy (TEM)
TEM was conducted to visualize the presence of capsu-
lar material. Isolates from overnight cultures were fixed
in situ on agar plates, and processed according to the
protocol developed by Hammerschmidt et al. with
ruthenium red and L-lysine acetate fixation [30]. In
addition, three clinical isolates with confirmed serotyp-
ing results (one serotype 1 and two NT) were selected
from the GERMS-SA collection and were included as
controls for TEM analysis.
Genome sequencing
Overnight fresh cultures were inoculated into brain
heart infusion broth (DMP) and incubated overnight at
37 °C in 5 % CO2. Cells were pre-lysed at 37 °C for 1 h
in 10 mg/ml of lysozyme (Sigma-Aldrich, St. Louis, MO)
and DNA was extracted using the QIAamp DNA mini
kit (Qiagen, Venlo, Netherlands). DNA extracts were
quantified using the Qubit instrument and dsDNA BR
Assay kit (Life Technologies, Carlsbad, CA, USA). Multi-
plexed paired-end libraries were prepared using the
Nextera XT DNA sample preparation kit (Illumina, San
Diego, CA, USA). Genome sequencing was carried out
on an Illumina MiSeq platform. Each isolate was
extracted and sequenced three times, each time from a
fresh culture.
Genome analysis
The paired-end reads were checked for quality, trimmed
and de novo assembled using the Qiagen CLC Genomics
Workbench version 8 (Qiagen, Venlo, Netherlands). The
resultant contiguous sequences were then ordered using
Mauve [31] and S. pneumoniae ATCC 700669 as a refer-
ence [GenBank:FM211187] and annotated using Prokka
version 1.11 [32]. In addition the sequenced reads
were mapped against references for capsular regions
of co-detected serotypes [GenBank: CR931632 and
CR931673].
Variations within the capsular polysaccharide biosyn-
thesis genes were detected using the fixed ploidy variant
detection tool within the CLC Genomics Workbench.
This model detects the variants whose representation in
the reads is in accordance with the assumed ploidy, dis-
cards variants whose representation in the reads is likely
due to sequencing errors or mapping artefacts and then
reports on positions where there may be single nucleo-
tide variation (SNV) including insertions, deletions and
substitutions. Identified variations were further investi-
gated using CLC Genomic workbench to identify amino
acid changes.
Sequences of the 7 multilocus sequence typing
(MLST) genes were extracted from the assembled
genomes and allele numbers and sequence types (ST)
assigned using the Bio-MLST-Check module (http://
search.cpan.org/dist/Bio-MLST-Check/lib/Bio/MLST/
Check.pm). Furthermore, contiguous sequences were
uploaded to the S. pneumoniae PubMLST isolates data-
base [12], which runs the Bacterial Isolate Genome Se-
quence database (BIGSdb) platform to facilitate the
ribosomal MLST (rMLST) analysis [33]. Phylogenetic
similarity analysis, based on the core genomes, was per-
formed using the Rapid large-scale prokaryote pan gen-
ome analysis (Roary) [34] and the maximum likelihood
trees were generated using RaxML version 8 [35]. The
genomes of case A and case B isolates were compared to
serotype 1 (n = 54) and 18C (n = 58) genomes randomly
selected from sequences available on S. pneumoniae
PubMLST database [12]. The selected sequences were of
serotype 1 and 18C isolates that caused IPD in South Af-
rica from 1989 to 2013 and 2005 to 2013, respectively.
For the analysis, core genomes consisted of genes that
were present as single copies in at least 90 % of isolates
being analysed and, in addition, had the same sequence
length in every isolate. The BLAST Ring Image Gener-
ator (BRIG) was used to visualise similarities between
genomes of mixed culture isolates [36].
Additional files
Additional file 1: Figure S1. BLAST Ring Image of the complete genome
sequence of a non-serotypeable and serotype 1 isolate. This figure shows
comparison between genome sequence of a non-serotypeable (NT) isolate
co-detected with a serotype 1 isolate during a single episode of invasive
disease in South Africa in 2009 and genome sequences of a serotype 1 isolate
of the same sequence type (ST) 217 and ribosomal ST3462 as the NT isolate.
(PDF 191 kb)
Additional file 2: Figure S2. Core genome phylogenetic tree of Case A
non-serotypeable isolate and serotype 1 isolates from South Africa. The
tree represents phylogenetic comparison of the core genome of a non-
serotypeable (NT) co-detected with a serotype 1 isolate in 2009 in South
Africa and genomes of serotype 1 isolates (n = 54) that caused invasive
disease in South Africa from 1989 to 2013. This maximum likelihood tree
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was built using core gene sequences which were concatenated and
aligned, using MUSCLE (EMBL-EBI). The numbers at the nodes indicate
RAxML bootstrap values. Branch lengths are proportional to the number
of substitutions per site (see the scale bars). The colour coding is according
to sequence type (ST). (PDF 173 kb)
Additional file 3: Figure S3. Comparison of wchA gene sequences of
18C and non-serotypeable isolates from a South African patient. Amino
acid sequences of wchA genes of two isolates [serotype 18C and non-
serotypeable (NT)] recovered simultaneously from a patient with invasive
pneumococcal disease in South Africa in 2010 were aligned to identify
differences between the two sequences. The region where the NT amino
acid sequence differs from the 18C sequence is enclosed in a box. Position
of a stop codon within the NT amino acid sequence is indicated by an
asterisk (*). (PDF 150 kb)
Additional file 4: Figure S4. Comparison of wze gene sequences of 18C
and non-serotypeable isolates from a South African patient. This figure
shows amino acid sequence alignment of wze genes of two isolates
[serotype 18C and non-serotypeable (NT)] recovered from a patient with
invasive pneumococcal disease in South Africa is shown. The box indicates
a variable amino acid due to a single nucleotide variation between the two
isolates. (PDF 177 kb)
Additional file 5: Figure S5. BLAST Ring Image (BRIG) of the complete
genome sequence of a non-serotypeable and serotype 18C isolate. This
figure visualise similarities between genomes of mixed culture isolates.
The two isolates [serotype 18C and non-serotypeable (NT)] were co-
detected during a single episode of invasive disease in South Africa in
2010. (PDF 197 kb)
Additional file 6: Figure S6. Core genome phylogeny of a non-
serotypeable isolate and serotype 18C isolates from South Africa. The tree
represents phylogenetic comparison of the core genome of two isolates
that were co-detected during a single episode of invasive disease in
South Africa in 2010 [serotype 18C and non-serotypeable (NT)] and
genomes of serotype 18C isolates (n = 58) that caused invasive disease in
South Africa from 2005 to 2013. This maximum likelihood tree was built
using core gene sequences which were concatenated and aligned, using
MUSCLE (EMBL-EBI). The numbers at the nodes indicate RAxML bootstrap
values. Branch lengths are proportional to the number of substitutions
per site (see the scale bars). The colour coding is according to sequence
type (ST). (PDF 164 kb)
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